<DOC>
	<DOCNO>NCT01127100</DOCNO>
	<brief_summary>Gabapentin first line medication fentanyl second line medication neuropathic pain . But , head head study efficacy medication neuropathic pain . The hypothesis study efficacy transdermal fentanyl matrix inferior gabapentin neuropathic pain .</brief_summary>
	<brief_title>Gabapentin Versus Transdermal Fentanyl Matrix Chronic Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>patient 20 year age old patient chronic pain 3 month average pain score last 3 day less 4 ( NRS ) neuropathic pain cause spinal stenosis ( radiate pain , motor sensory change positive MRI find radiculopathy confirm EMG/NCS le 12 point SLANSS score assessment patient make questionnaire patient agree informed consent patient experience gabapentin , pregabalin , fentanyl matrix , longacting strong opioid ( CR oxycodone , SR morphine ) patient cause neuropathy hypothyroidism , Vit B12 deficiency , connective tissue disease , etc . patient disease cause pain compare neuropathic pain patient history drug alcohol abuse patient pregnant possibility pregnancy patient unable use transdermal system due skin disease patient serious mental disease patient history hypersensitivity opioid analgesic patient chronic pulmonary disease respiratory depression patient combine industrial accident traffic accident investigator 's discretion , condition subject take part clinical study ground warning , caution , prohibition study investigator 's brochure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>neuropathic pain</keyword>
	<keyword>gabapentin</keyword>
	<keyword>transdermal fentanyl matrix</keyword>
	<keyword>multicenter</keyword>
	<keyword>non-inferiority trial</keyword>
</DOC>